Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study.
about
Lymph node dissection (lymphadenectomy) for presumed early stage epithelial ovarian cancerIntravesical bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancerStage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literatureCancer registries in Europe-going forward is the only optionCancer Patients' Survival: Standard Calculation Methods And Some Considerations Regarding Their Interpretation: POPULACIJSKO PREŽIVETJE BOLNIKOV Z RAKOM: UPORABA RAZLIČNIH PRISTOPOV IN PROBLEMI INTERPRETACIJE REZULTATOVNutritional Care of Gastric Cancer Patients with Clinical Outcomes and Complications: A ReviewChemotherapy of ovarian cancer in elderly patientsProfile of panitumumab as first-line treatment in patients with wild-type KRAS metastatic colorectal cancerHER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the StomachCancer research in need of a scientific revolution: Using 'paradigm shift' as a method of investigationClinical epidemiology of epithelial ovarian cancer in the UKResearch progress of thyroid transcription factor-1 as molecular marker in lung carcinomaLong non-coding RNAs in gastric cancer: versatile mechanisms and potential for clinical translationThe prevention, detection and management of cancer treatment-induced cardiotoxicity: a meta-reviewMultiscale Mechano-Biological Finite Element Modelling of Oncoplastic Breast Surgery-Numerical Study towards Surgical Planning and Cosmetic Outcome PredictionUpdate on Poly-ADP-ribose polymerase inhibition for ovarian cancer treatmentBevacizumab in ovarian cancer: A critical review of phase III studiesResection of Large Metachronous Liver Metastasis with Gastric Origin: Case Report and Review of the LiteratureAffluence and Private Health Insurance Influence Treatment and Survival in Non-Hodgkin's LymphomaDendritic cell-activated cytokine-induced killer cell-mediated immunotherapy is safe and effective for cancer patients >65�years oldAn Association of Cancer Physicians' strategy for improving services and outcomes for cancer patientsThe global burden of women's cancers: a grand challenge in global health.Improving early diagnosis of symptomatic cancer.Defining a standard set of patient-centred outcomes for lung cancer.Challenging Perceptions About Oncology Product Pricing in Breast and Colorectal Cancer.Reflection of illness and strategies for handling advanced lung cancer - a qualitative analysis in patients and their relativesPolicy: EU data protection regulation--harming cancer research.Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).Primary care characteristics and stage of cancer at diagnosis using data from the national cancer registration service, quality outcomes framework and general practice informationAge-specific cancer survival in Estonia: recent trends and data quality.Socioeconomic inequalities in stillbirth rates in Europe: measuring the gap using routine data from the Euro-Peristat ProjectIncidence and characteristics of chronic renal replacement therapy in patients with cancer: data from kidney and cancer registries in Basse-Normandie.Patient perspectives on delays in diagnosis and treatment of cancer: a qualitative analysis of free-text data.Dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian tube, or primary peritoneal carcinomas.Highlights from the ninth European breast cancer conference, glasgow, 19-21 march 2014Urban-Rural Variations in Quality-of-Life in Breast Cancer Survivors Prescribed Endocrine Therapy.Trends in oral cavity, pharyngeal, oesophageal and gastric cancer mortality rates in Spain, 1952-2006: an age-period-cohort analysisHigh BMI1 mRNA expression in peripheral whole blood is associated with favorable prognosis in advanced non-small cell lung cancer patientsIncreasing late stage colorectal cancer and rectal cancer mortality demonstrates the need for screening: a population based study in Ireland, 1994-2010Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments.
P2860
Q24187026-B4424E90-93CA-4EB2-8778-328B4BB2A9C2Q24188295-F87F22F5-72AF-4E70-8A81-EEB9D2364D0BQ26745767-DC92D969-CB01-4DA2-8744-D51EC5BB0035Q26746893-2105FD79-2CBB-4D48-B763-A3F2B90C8881Q26747151-460087E5-D1EF-45F6-8F3A-94A7B43989BDQ26751521-EBAD763C-9E37-430C-AE27-CECE613EAC3BQ26771397-35818DD5-2AE7-42A4-A6C7-1507A22E21D7Q26771952-7951AD15-065B-4ADF-B97D-C2403041D1BBQ26780318-D969C07A-9A16-4D6B-A5BD-56E19322904FQ26786406-262A08EA-3D10-4F51-9839-CAA47F3E9D08Q26822648-96BABA6A-C428-4F72-9CF9-0079082A7545Q26826821-0078F1BF-00E1-44AA-B02A-41DB5B29BD41Q26996377-877A509C-6B3D-484C-8430-58A879BA1B9AQ27010466-21E155B6-3349-4E65-936B-D146CC402854Q27333186-0B9B6AEC-C3DE-4800-AB3A-9E82F1BB838AQ28075761-F2CEB8A1-9AC1-49D5-BCAD-ECC56FD952B9Q28076188-9587709A-F5F0-4D5E-B695-E2E8E8E5191DQ28079913-5F95CBF3-218A-48E8-A69B-C9FDC5910636Q28354077-6134A216-B4F8-48BE-B526-76F862442DC5Q28468347-91E9712E-3A4A-44AB-A042-0D071170755FQ28603931-6DB55D21-8694-4EEE-BFC8-C223701E5D8BQ30241791-F56EDA46-D0E3-4AD3-A3A2-8DE2E596C7CFQ30242053-6F4107E7-B806-4B4C-8206-A9D9653D9A4BQ30276400-B0D17E65-2E1F-4003-B64A-C13C953AAF04Q30490454-43F2354B-1A6A-4909-847F-819424405227Q30840411-0D824550-77D6-46C7-92FF-276A9D1B4ECFQ30846979-A7C13743-7337-4E45-AC08-88282771CA1BQ30873972-232AB6F2-D923-4DA7-94DF-734DA78003B9Q30978482-479ADF66-CC66-4604-BB5A-27AF7F8998B4Q30985736-8D6C9E00-23E7-44CD-A9D7-D6182E5E8CA8Q31039828-A6181BC4-B353-487F-9F1C-F68F2284F198Q31141059-310C3350-FECF-406E-B124-6AA81CEB475FQ31143804-0FC03289-2FB7-46A3-B1FA-E8A7D5498E37Q33436678-B176B7B7-EEF5-406B-803D-F486701C6008Q33604253-FB474FED-5BA2-4BEE-83E4-6EBDAC56A7FBQ33616178-4FFA419B-0909-4AB5-A6FE-3FA5369C3C92Q33617489-FCF54497-9C85-45BA-8E5D-87732ADFDC80Q33648891-8928DBFE-A72D-4993-ABCA-4FCF9B77EA7DQ33700674-89042DC1-5681-4BCD-BFA4-1804B2FE6622Q33712944-4F9DA4BD-A6B9-4B8F-9430-7968B5AEA8D3
P2860
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Cancer survival in Europe 1999 ...... E--5-a population-based study.
@en
type
label
Cancer survival in Europe 1999 ...... E--5-a population-based study.
@en
prefLabel
Cancer survival in Europe 1999 ...... E--5-a population-based study.
@en
P2093
P50
P1433
P1476
Cancer survival in Europe 1999 ...... E--5-a population-based study.
@en
P2093
Alice Nennecke
Annalisa Trama
Daniela Pierannunzio
EUROCARE-5 Working Group
Franco Berrino
Gerda Engholm
Otto Visser
Riccardo Capocaccia
Sabine Siesling
P356
10.1016/S1470-2045(13)70546-1
P50
P577
2013-12-05T00:00:00Z